Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brenipatide in moderate-to-severe COPD
NCT07759245Phase 2Recruiting
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2026
- Primary completion
- May 2028
- Countries
- 18
01
Overview
A Phase 2 trial of brenipatide in chronic obstructive pulmonary disease (COPD), sponsored by Eli Lilly and Company. Started Aug 2026; status: recruiting.
02
Drugs
brenipatide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT07759245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07759245.